Effect of 2nd line pazopanib (PZN) on the number and phenotype of CTCs in patients with small cell lung cancer.

Ippokratis Messaritakis,Eleni Politaki,Stella Apostolaki,Maria Plataki,Filippos Koinis,Nikolaos Vovolinis,Eleftheria Kleio Dermitzaki,Vassilis Georgoulias,Athanasios Kotsakis

Effect of 2nd line pazopanib (PZN) on the number and phenotype of CTCs in patients with small cell lung cancer.

2016

Ippokratis Messaritakis
Eleni Politaki
Stella Apostolaki
Maria Plataki
Filippos Koinis
Nikolaos Vovolinis
Eleftheria Kleio Dermitzaki
Vassilis Georgoulias
Athanasios Kotsakis

8562Background: To investigate the effect of 2nd line PZN on the number and phenotype of CTCs in patients with SCLC. Methods: CTCs were detected in58 pts using the CelleSearch assay (CS) and double...

Keywords:

Cell
Pazopanib
Phenotype
Lung cancer
Pathology
Medicine
in patient
Cancer research
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations